RevBio Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$15M
- Investors
-
18
RevBio General Information
Description
Developer of regenerative adhesive biomaterial, designed to facilitate bone repair and regeneration in medical procedures. The company offers an injectable, biocompatible material that adheres to wet bone, promotes new bone growth, and resorbs over time, enabling dental and orthopedic specialists with stable fixation and support for natural healing.
Contact Information
Website
www.revbio.comCorporate Office
- 600 Suffolk Street
- Suite 250
- Lowell, MA 01854
- United States
Corporate Office
- 600 Suffolk Street
- Suite 250
- Lowell, MA 01854
- United States
RevBio Timeline
RevBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Later Stage VC | 02-Oct-2026 | $15M | Completed | Clinical Trials - Phase 2 | ||
| 17. Grant | 06-Oct-2025 | Completed | Clinical Trials - Phase 2 | |||
| 16. Later Stage VC | 10-Feb-2023 | Completed | Clinical Trials - Phase 2 | |||
| 15. Grant | 29-Mar-2023 | Completed | Clinical Trials - Phase 1 | |||
| 14. Later Stage VC | 30-Jan-2023 | Completed | Startup | |||
| 13. Accelerator/Incubator | 01-Jun-2022 | Completed | Startup | |||
| 12. Seed Round | 24-May-2022 | Completed | Startup | |||
| 11. Grant | 27-Apr-2022 | Completed | Clinical Trials - Phase 1 | |||
| 10. Grant | 06-Apr-2021 | $2M | $9.6M | Completed | Startup | |
| 9. Grant | 02-Jun-2020 | $4.56M | $9.6M | Completed | Startup |
RevBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2-2 | ||||||||
| Seed 2-1 | ||||||||
| Seed-6 | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 2,502,727 | $0.001000 | $1.52 | $1.52 | 1x | $1.52 | 8.79% | |
| Seed-1 | 2,239,141 | $0.001000 | $1.79 | $1.79 | 1x | $1.79 | 7.86% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
RevBio Comparisons
Industry
Financing
Details
RevBio Competitors (12)
One of RevBio’s 12 competitors is Cerapedics, a Venture Capital-Backed company based in Westminster, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cerapedics | Venture Capital-Backed | Westminster, CO | ||||
| Abyrx | Formerly VC-backed | Stamford, CT | ||||
| IlluminOss | Private Equity-Backed | East Providence, RI | ||||
| EpiBone | Venture Capital-Backed | New York, NY | ||||
| Reapplix | Venture Capital-Backed | Birkerod, Denmark |
RevBio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RevBio Patents
RevBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023314418-A1 | Adhesive compositions with tunable porosity and acidity content and methods of use thereof | Pending | 28-Jul-2022 | ||
| EP-4561642-A1 | Adhesive compositions with tunable porosity and acidity content and methods of use thereof | Pending | 28-Jul-2022 | ||
| EP-4561642-A4 | Adhesive compositions with tunable porosity and acidity content and methods of use thereof | Pending | 28-Jul-2022 | ||
| US-20260041812-A1 | Adhesive compositions with tunable porosity and acidity content and methods of use thereof | Pending | 28-Jul-2022 | ||
| WO-2024026121-A1 | Adhesive compositions with tunable porosity and acidity content and methods of use thereof | Inactive | 28-Jul-2022 | A61L24/0036 |
RevBio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RevBio Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Greyhill Capital Partners | Venture Capital | Minority | ||
| Revere Partners | Venture Capital | Minority | ||
| Pacific Dental Services | Corporation | Minority | ||
| The JHA Capital | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority |
RevBio FAQs
-
When was RevBio founded?
RevBio was founded in 2014.
-
Where is RevBio headquartered?
RevBio is headquartered in Lowell, MA.
-
What is the size of RevBio?
RevBio has 38 total employees.
-
What industry is RevBio in?
RevBio’s primary industry is Surgical Devices.
-
Is RevBio a private or public company?
RevBio is a Private company.
-
What is RevBio’s current revenue?
The current revenue for RevBio is .
-
How much funding has RevBio raised over time?
RevBio has raised $50.7M.
-
Who are RevBio’s investors?
Greyhill Capital Partners, Revere Partners, Pacific Dental Services, The JHA Capital, and MedTech Innovator are 5 of 18 investors who have invested in RevBio.
-
Who are RevBio’s competitors?
Cerapedics, Abyrx, IlluminOss, EpiBone, and Reapplix are some of the 12 competitors of RevBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
